TITLE:
Application of Cystatin C Combined with Homocysteine Detection in AIDS and Tuberculosis Complicated with Hypertension
AUTHORS:
Jianhong Qin, Chaojuan Liang, Xiaoyu Jiang, Zhizong Pan, Lida Mo
KEYWORDS:
Cystatin C, Homocysteine, AIDS, Tuberculosis, Hypertension
JOURNAL NAME:
Advances in Bioscience and Biotechnology,
Vol.14 No.4,
April
24,
2023
ABSTRACT: Objective: To investigate the
application of cystatin C combined with homocysteine detection in AIDS and
tuberculosis complicated with hypertension. Methods: 57 patients with
AIDS complicated with hypertension and 52 patients with tuberculosis
complicated with hypertension from Guangxi Infectious Diseases Hospital Nanning
Fourth People’s Hospital/Guangxi AIDS Clinical Treatment Center (Nanning) from
October 2022 to March 2023, and 196 patients with simple hypertension from
Guangxi Cardiovascular Diseases Hospital Nanning Third People’s Hospital were
selected as research objects. And then the difference in the detection results
of cystatin C and homocysteine among the three groups was compared. Results: The detection results of serum cystatin C and homocysteine in AIDS patients
with hypertension and tuberculosis patients with hypertension were higher than
those in the simple hypertension group, and
the difference was statistically significant (P 0.05). Conclusion: The detection of cystatin
C combined with homocysteine has high clinical application value in AIDS with
hypertension and tuberculosis with hypertension. When AIDS is combined with
hypertension or tuberculosis is combined with hypertension, cystatin C and
homocysteine are at a high level, while the concentration levels of cystatin C
and homocysteine are relatively low in simple hypertension. Therefore, cystatin
C combined with homocysteine detection can provide better laboratory evidence
for clinical diagnosis and differential diagnosis, and is worth promoting and
applying.